Paola Alberti

University University of Milano-Bicocca
Department School of Medicine and Surgery
  • July 2010: Degree: MD – 110/110 cum laude – University of Milano-Bicocca (Monza, Italy)
  • June 2016 – Degree: Board in Neurology – 70/70 cum laude – University of Milano-Bicocca (Monza, Italy)
  • February 2019Degree: PhD in Neuroscience – University of Milano-Bicocca (Monza, Italy)
RESEARCH INTEREST AND PROFESSIONAL EXPERIENCE Since she was an undergraduate student in Medicine and Surgery, she has been actively involved in Chemotherapy Induced Peripheral Neurotoxicity (CIPN) research, taking part to the international US/EU multicenter clinical trial/group, CI-PeriNomS. She is now an active member of the Toxic Neuropathy Consortium (TNC,, part of the Peripheral Nervous System (PNS) society ( During the Residency in Neurology she developed an interest in neurophysiology and was a visiting fellow at Johns Hopkins University (Prof. D.R. Cornblath, MD). Since 2015 she developed an interest also for preclinical CIPN research and joined the “in vivo group” at the Experimental Neurology Unit (ENU, University of Milano-Bicocca). She was enrolled in the PhD program in Neuroscience (Head: Prof. G. Cavaletti, MD), at the same University, obtaining the PhD degree in 2019. Her PhD project was focused on Oxaliplatin Induced Peripheral Neurotoxicity in rodent models: she introduced advanced neurophysiological techniques, nerve excitability testing, to ENU after having learnt them from Prof H. Bostock, (UCL, London). She also learned invasive DRG recordings in in vivo rodent models (Baltimore, Prof. S.G. Dorsey and Prof C. Renn). Since August 2016 she has been given a clinical position as Neurologist/Neurophysiologist at San Gerardo Hospital (ASST Monza, Italy): she is the treating physician for outpatients affected by CIPN (“Ambulatorio di Fragilità Neurologica”).
Research Areas
Laboratories Experimental Neurology Unit